GH Research PLC (GHRS)
NASDAQ·Healthcare·Biotechnology
$19.51
-0.46%
Mkt Cap $1.17B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | — | — | — | -$0.29 | -$0.23 | +20.69% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.23 | -$0.23 | +0.00% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.22 | -$0.15 | +31.82% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.61 | -$0.19 | +68.85% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.23 | -$0.17 | +26.09% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.25 | -$0.23 | +8.00% | — | — |
| Q3 2024 Sep 3, 2024 | — | — | — | -$0.23 | -$0.20 | +13.04% | — | — |
| Q2 2024 May 3, 2024 | — | — | — | -$0.22 | -$0.15 | +31.82% | — | — |
| Q1 2024 Feb 29, 2024 | — | — | — | -$0.20 | -$0.21 | -5.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.20 | -$0.11 | +45.00% | — | — |
| Q3 2023 Aug 23, 2023 | — | — | — | -$0.25 | -$0.15 | +40.00% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.22 | -$0.21 | +4.55% | — | — |
| Q1 2023 Mar 2, 2023 | — | — | — | -$0.17 | -$0.32 | -88.24% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.17 | -$0.01 | +94.12% | — | — |
| Q3 2022 Aug 23, 2022 | — | — | — | -$0.17 | -$0.12 | +29.41% | — | — |
| Q2 2022 May 18, 2022 | — | — | — | -$0.16 | -$0.11 | +31.25% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$0.17 | -$0.09 | +47.06% | — | — |
| Q4 2021 Dec 6, 2021 | — | — | — | -$0.10 | -$0.04 | +60.00% | — | — |
| Q3 2021 Sep 23, 2021 | — | — | — | -$0.08 | -$0.05 | +37.50% | — | — |
| Q2 2021 Jun 28, 2021 | — | — | — | — | -$0.02 | — | — | — |